Monographie - Acetylsalicylic acid lysinate

Viimeisin päivitys :
28/04/2024

Acetylsalicylic acid lysinate

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acetilsalicinato de lisina	Portugali
Aspegic	Belgia, Chile, Espanja, Hollanti, Italia, Luxemburg, Marokko, Portugali, Ranska, Sveitsi, Tunisia
Aspidol	Italia
Aspirin IV	Saksa
Aspirina Richet	Argentiina
Aspisol	Saksa
Flectadol	Italia
Inyesprin	Espanja
Kardegic	Ranska, Unkari
Kardiren	Unkari
Laspal	Puola

Viitteet : Acetylsalicylic acid lysinate

	Tyyppi	Julkaisu
1859	Lehti	Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G. Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy. Il Farmaco 2002 ; 57: 925-930.
2139	Lehti	Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. EJHP Science 2006 ; 12,5: 96-99.
2212	Laboratorio	Reteplase (Rapilysin®) - Summary of Product Characteristics Actavis UK Ltd 2015
3838	Laboratorio	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
4698	Lehti	Ayari G, D'Huart E, Vigneron J, Demoré B. Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs. Pharmaceutical Technology in Hospital Pharmacy 2022

Mentions Légales